SEC Filing Reveals Xoma Corp. Insider Transaction on July 10, 2015
According to the U.S. Securities and Exchange Commission (SEC) filing by Xoma Corp. (Form 4), on July 10, 2015, an insider transaction was submitted. The filing, accessible on the SEC website, provides details about the document filed with this form. The SEC filing is a formal document submitted by publicly-traded companies, offering insights into corporate dealings.
Key Takeaways:
- The SIC code for Xoma Corp. is 2834, indicating the company operates within the Pharmaceutical Preparations sector.
- The SEC filing revealed that one document was submitted with the form, revealing information about the reporting person's relationship to the company and their equity transactions.
- The form is part of the SEC's requirement for directors, officers, or owners with more than ten percent of a class of equity securities to report their beneficial ownership and transactions.
- The SEC filing process involves Forms 3, 4, and 5, with Form 4 specifically used to report changes in beneficial ownership.
- Xoma Corp.'s contact information is listed as 2910 SEVENTH ST, BERKELEY CA 94710, with a phone number of 5106441170.
Statistics:
- One document was filed with the SEC filing.
- The SEC filing is accessible on the SEC website (http://www.sec.gov/Archives/edgar/data/1210905/0000791908-15-000087-index.html).
- The SIC code for Xoma Corp. is 2834.
- The SEC filing is a formal document submitted by publicly-traded companies.
Sources:
- NewsRx LLC, 2015 JUL 27, "U.S. Securities and Exchange Commission (SEC) Filing by Xoma Corp."
- U.S. Securities and Exchange Commission (SEC) website (http://www.sec.gov)
Note: The sources listed above are the only ones explicitly mentioned in the provided text.